시장조사 보고서 : 세계의 안과 약물 및 기기 시장예측 2021년-2026년

■ 영문 제목 : Global Opthalmology Drugs and Devices Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02251 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 100 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 안과 약물 및 기기의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (디바이스, 의약품)와 용도별 시장규모 (병원, 클리닉, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 안과 약물 및 기기 시장 점유율
- 지역별 안과 약물 및 기기 시장규모
- 주요지역의 종류별 시장규모 (디바이스, 의약품)
- 주요지역의 용도별 시장규모 (병원, 클리닉, 기타)
- 미주의 안과 약물 및 기기 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 안과 약물 및 기기 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 안과 약물 및 기기 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 안과 약물 및 기기 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 안과 약물 및 기기 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Merck (US), Pfizer (US), Roche Holdings (Switzerland), Santen Pharmaceutical(Japan), Alcon (Switzerland), Bausch & Lomb (US), Carl Zeiss Meditec (Germany), Essilor International S.A. (France), Johnson & Johnson (US), Nidek(Japan), Topcon Corporation (Japan)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Opthalmology Drugs and Devices will have significant change from previous year. By the most conservative estimates of global Opthalmology Drugs and Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Opthalmology Drugs and Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Opthalmology Drugs and Devices market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Device
Drug

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hosptial
Clinic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
Nidek(Japan)
Topcon Corporation (Japan)

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opthalmology Drugs and Devices Market Size 2016-2026
2.1.2 Opthalmology Drugs and Devices Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Opthalmology Drugs and Devices Segment by Type
2.2.1 Device
2.2.2 Device
2.3 Opthalmology Drugs and Devices Market Size by Type
2.3.1 Global Opthalmology Drugs and Devices Market Size CAGR by Type
2.3.2 Global Opthalmology Drugs and Devices Market Size Market Share by Type (2016-2021)
2.4 Opthalmology Drugs and Devices Segment by Application
2.4.1 Hosptial
2.4.2 Clinic
2.4.3 Others
2.5 Opthalmology Drugs and Devices Market Size by Application
2.5.1 Global Opthalmology Drugs and Devices Market Size CAGR by Application
2.5.2 Global Opthalmology Drugs and Devices Market Size Market Share by Application (2016-2021)

3 Opthalmology Drugs and Devices Market Size by Players
3.1 Opthalmology Drugs and Devices Market Size Market Share by Players
3.1.1 Global Opthalmology Drugs and Devices Revenue by Players (2019-2021E)
3.1.2 Global Opthalmology Drugs and Devices Revenue Market Share by Players (2019-2021E)
3.2 Global Opthalmology Drugs and Devices Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Opthalmology Drugs and Devices by Regions
4.1 Opthalmology Drugs and Devices Market Size by Regions (2016-2021)
4.2 Americas Opthalmology Drugs and Devices Market Size Growth (2016-2021)
4.3 APAC Opthalmology Drugs and Devices Market Size Growth (2016-2021)
4.4 Europe Opthalmology Drugs and Devices Market Size Growth (2016-2021)
4.5 Middle East & Africa Opthalmology Drugs and Devices Market Size Growth (2016-2021)

5 Americas
5.1 Americas Opthalmology Drugs and Devices Market Size by Country (2016-2021)
5.2 Americas Opthalmology Drugs and Devices Market Size by Type (2016-2021)
5.3 Americas Opthalmology Drugs and Devices Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Opthalmology Drugs and Devices Market Size by Region (2016-2021)
6.2 APAC Opthalmology Drugs and Devices Market Size by Type (2016-2021)
6.3 APAC Opthalmology Drugs and Devices Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Opthalmology Drugs and Devices by Country (2016-2021)
7.2 Europe Opthalmology Drugs and Devices Market Size by Type (2016-2021)
7.3 Europe Opthalmology Drugs and Devices Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Opthalmology Drugs and Devices by Region (2016-2021)
8.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2016-2021)
8.3 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Opthalmology Drugs and Devices Market Forecast
10.1 Global Opthalmology Drugs and Devices Forecast by Regions (2021-2026)
10.1.1 Global Opthalmology Drugs and Devices Forecast by Regions (2021-2026)
10.1.2 Americas Opthalmology Drugs and Devices Forecast
10.1.3 APAC Opthalmology Drugs and Devices Forecast
10.1.4 Europe Opthalmology Drugs and Devices Forecast
10.1.5 Middle East & Africa Opthalmology Drugs and Devices Forecast
10.2 Americas Opthalmology Drugs and Devices Forecast by Countries (2021-2026)
10.2.1 United States Opthalmology Drugs and Devices Market Forecast
10.2.2 Canada Opthalmology Drugs and Devices Market Forecast
10.2.3 Mexico Opthalmology Drugs and Devices Market Forecast
10.2.4 Brazil Opthalmology Drugs and Devices Market Forecast
10.3 APAC Opthalmology Drugs and Devices Forecast by Region (2021-2026)
10.3.1 China Opthalmology Drugs and Devices Market Forecast
10.3.2 Japan Opthalmology Drugs and Devices Market Forecast
10.3.3 Korea Opthalmology Drugs and Devices Market Forecast
10.3.4 Southeast Asia Opthalmology Drugs and Devices Market Forecast
10.3.5 India Opthalmology Drugs and Devices Market Forecast
10.3.6 Australia Opthalmology Drugs and Devices Market Forecast
10.4 Europe Opthalmology Drugs and Devices Forecast by Country (2021-2026)
10.4.1 Germany Opthalmology Drugs and Devices Market Forecast
10.4.2 France Opthalmology Drugs and Devices Market Forecast
10.4.3 UK Opthalmology Drugs and Devices Market Forecast
10.4.4 Italy Opthalmology Drugs and Devices Market Forecast
10.4.5 Russia Opthalmology Drugs and Devices Market Forecast
10.5 Middle East & Africa Opthalmology Drugs and Devices Forecast by Region (2021-2026)
10.5.1 Egypt Opthalmology Drugs and Devices Market Forecast
10.5.2 South Africa Opthalmology Drugs and Devices Market Forecast
10.5.3 Israel Opthalmology Drugs and Devices Market Forecast
10.5.4 Turkey Opthalmology Drugs and Devices Market Forecast
10.5.5 GCC Countries Opthalmology Drugs and Devices Market Forecast
10.6 Global Opthalmology Drugs and Devices Forecast by Type (2021-2026)
10.7 Global Opthalmology Drugs and Devices Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Merck (US)
11.1.1 Merck (US) Company Information
11.1.2 Merck (US) Opthalmology Drugs and Devices Product Offered
11.1.3 Merck (US) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Merck (US) Main Business Overview
11.1.5 Merck (US) Latest Developments
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Information
11.2.2 Pfizer (US) Opthalmology Drugs and Devices Product Offered
11.2.3 Pfizer (US) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Pfizer (US) Main Business Overview
11.2.5 Pfizer (US) Latest Developments
11.3 Roche Holdings (Switzerland)
11.3.1 Roche Holdings (Switzerland) Company Information
11.3.2 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Product Offered
11.3.3 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Roche Holdings (Switzerland) Main Business Overview
11.3.5 Roche Holdings (Switzerland) Latest Developments
11.4 Santen Pharmaceutical(Japan)
11.4.1 Santen Pharmaceutical(Japan) Company Information
11.4.2 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Product Offered
11.4.3 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Santen Pharmaceutical(Japan) Main Business Overview
11.4.5 Santen Pharmaceutical(Japan) Latest Developments
11.5 Alcon (Switzerland)
11.5.1 Alcon (Switzerland) Company Information
11.5.2 Alcon (Switzerland) Opthalmology Drugs and Devices Product Offered
11.5.3 Alcon (Switzerland) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Alcon (Switzerland) Main Business Overview
11.5.5 Alcon (Switzerland) Latest Developments
11.6 Bausch & Lomb (US)
11.6.1 Bausch & Lomb (US) Company Information
11.6.2 Bausch & Lomb (US) Opthalmology Drugs and Devices Product Offered
11.6.3 Bausch & Lomb (US) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Bausch & Lomb (US) Main Business Overview
11.6.5 Bausch & Lomb (US) Latest Developments
11.7 Carl Zeiss Meditec (Germany)
11.7.1 Carl Zeiss Meditec (Germany) Company Information
11.7.2 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Product Offered
11.7.3 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Carl Zeiss Meditec (Germany) Main Business Overview
11.7.5 Carl Zeiss Meditec (Germany) Latest Developments
11.8 Essilor International S.A. (France)
11.8.1 Essilor International S.A. (France) Company Information
11.8.2 Essilor International S.A. (France) Opthalmology Drugs and Devices Product Offered
11.8.3 Essilor International S.A. (France) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Essilor International S.A. (France) Main Business Overview
11.8.5 Essilor International S.A. (France) Latest Developments
11.9 Johnson & Johnson (US)
11.9.1 Johnson & Johnson (US) Company Information
11.9.2 Johnson & Johnson (US) Opthalmology Drugs and Devices Product Offered
11.9.3 Johnson & Johnson (US) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Johnson & Johnson (US) Main Business Overview
11.9.5 Johnson & Johnson (US) Latest Developments
11.10 Nidek(Japan)
11.10.1 Nidek(Japan) Company Information
11.10.2 Nidek(Japan) Opthalmology Drugs and Devices Product Offered
11.10.3 Nidek(Japan) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Nidek(Japan) Main Business Overview
11.10.5 Nidek(Japan) Latest Developments
11. Topcon Corporation (Japan)
11.11.1 Topcon Corporation (Japan) Company Information
11.11.2 Topcon Corporation (Japan) Opthalmology Drugs and Devices Product Offered
11.11.3 Topcon Corporation (Japan) Opthalmology Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Topcon Corporation (Japan) Main Business Overview
11.11.5 Topcon Corporation (Japan) Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Opthalmology Drugs and Devices Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Device
Table 3. Major Players of Drug
Table 4. Opthalmology Drugs and Devices Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Opthalmology Drugs and Devices Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Opthalmology Drugs and Devices Market Size Market Share by Type (2016-2021)
Table 7. Opthalmology Drugs and Devices Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Opthalmology Drugs and Devices Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Opthalmology Drugs and Devices Market Size Market Share by Application (2016-2021)
Table 10. Global Opthalmology Drugs and Devices Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Opthalmology Drugs and Devices Revenue Market Share by Players (2019-2021E)
Table 12. Opthalmology Drugs and Devices Key Players Head office and Products Offered
Table 13. Opthalmology Drugs and Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Opthalmology Drugs and Devices Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Opthalmology Drugs and Devices Market Size Market Share by Regions 2016-2021
Table 18. Americas Opthalmology Drugs and Devices Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Opthalmology Drugs and Devices Market Size Market Share by Country (2016-2021)
Table 20. Americas Opthalmology Drugs and Devices Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Opthalmology Drugs and Devices Market Size Market Share by Type (2016-2021)
Table 22. Americas Opthalmology Drugs and Devices Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Opthalmology Drugs and Devices Market Size Market Share by Application (2016-2021)
Table 24. APAC Opthalmology Drugs and Devices Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Opthalmology Drugs and Devices Market Size Market Share by Region (2016-2021)
Table 26. APAC Opthalmology Drugs and Devices Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Opthalmology Drugs and Devices Market Size Market Share by Type (2016-2021)
Table 28. APAC Opthalmology Drugs and Devices Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Opthalmology Drugs and Devices Market Size Market Share by Application (2016-2021)
Table 30. Europe Opthalmology Drugs and Devices Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Opthalmology Drugs and Devices Market Size Market Share by Country (2016-2021)
Table 32. Europe Opthalmology Drugs and Devices Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Opthalmology Drugs and Devices Market Size Market Share by Type (2016-2021)
Table 34. Europe Opthalmology Drugs and Devices Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Opthalmology Drugs and Devices Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Opthalmology Drugs and Devices Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Opthalmology Drugs and Devices Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Opthalmology Drugs and Devices Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Opthalmology Drugs and Devices Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Opthalmology Drugs and Devices
Table 43. Key Application and Potential Industries of Opthalmology Drugs and Devices
Table 44. Key Challenges of Opthalmology Drugs and Devices
Table 45. Key Trends of Opthalmology Drugs and Devices
Table 46. Global Opthalmology Drugs and Devices Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Opthalmology Drugs and Devices Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Opthalmology Drugs and Devices Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Opthalmology Drugs and Devices Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Opthalmology Drugs and Devices Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Opthalmology Drugs and Devices Market Size Market Share Forecast by Application (2021-2026)
Table 52. Merck (US) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 53. Merck (US) Opthalmology Drugs and Devices Product Offered
Table 54. Merck (US) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Merck (US) Main Business
Table 56. Merck (US) Latest Developments
Table 57. Pfizer (US) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 58. Pfizer (US) Opthalmology Drugs and Devices Product Offered
Table 59. Pfizer (US) Main Business
Table 60. Pfizer (US) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Pfizer (US) Latest Developments
Table 62. Roche Holdings (Switzerland) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 63. Roche Holdings (Switzerland) Opthalmology Drugs and Devices Product Offered
Table 64. Roche Holdings (Switzerland) Main Business
Table 65. Roche Holdings (Switzerland) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Roche Holdings (Switzerland) Latest Developments
Table 67. Santen Pharmaceutical(Japan) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 68. Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Product Offered
Table 69. Santen Pharmaceutical(Japan) Main Business
Table 70. Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Santen Pharmaceutical(Japan) Latest Developments
Table 72. Alcon (Switzerland) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 73. Alcon (Switzerland) Opthalmology Drugs and Devices Product Offered
Table 74. Alcon (Switzerland) Main Business
Table 75. Alcon (Switzerland) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Alcon (Switzerland) Latest Developments
Table 77. Bausch & Lomb (US) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 78. Bausch & Lomb (US) Opthalmology Drugs and Devices Product Offered
Table 79. Bausch & Lomb (US) Main Business
Table 80. Bausch & Lomb (US) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Bausch & Lomb (US) Latest Developments
Table 82. Carl Zeiss Meditec (Germany) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 83. Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Product Offered
Table 84. Carl Zeiss Meditec (Germany) Main Business
Table 85. Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Carl Zeiss Meditec (Germany) Latest Developments
Table 87. Essilor International S.A. (France) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 88. Essilor International S.A. (France) Opthalmology Drugs and Devices Product Offered
Table 89. Essilor International S.A. (France) Main Business
Table 90. Essilor International S.A. (France) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Essilor International S.A. (France) Latest Developments
Table 92. Johnson & Johnson (US) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 93. Johnson & Johnson (US) Opthalmology Drugs and Devices Product Offered
Table 94. Johnson & Johnson (US) Main Business
Table 95. Johnson & Johnson (US) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Johnson & Johnson (US) Latest Developments
Table 97. Nidek(Japan) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 98. Nidek(Japan) Opthalmology Drugs and Devices Product Offered
Table 99. Nidek(Japan) Main Business
Table 100. Nidek(Japan) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Nidek(Japan) Latest Developments
Table 102. Topcon Corporation (Japan) Details, Company Type, Opthalmology Drugs and Devices Area Served and Its Competitors
Table 103. Topcon Corporation (Japan) Opthalmology Drugs and Devices Product Offered
Table 104. Topcon Corporation (Japan) Opthalmology Drugs and Devices Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Topcon Corporation (Japan) Main Business
Table 106. Topcon Corporation (Japan) Latest Developments
List of Figures
Figure 1. Opthalmology Drugs and Devices Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Opthalmology Drugs and Devices Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Opthalmology Drugs and Devices Market Size Market Share by Type in 2020
Figure 7. Opthalmology Drugs and Devices in Hosptial
Figure 8. Global Opthalmology Drugs and Devices Market: Hosptial (2016-2021) & ($ Millions)
Figure 9. Opthalmology Drugs and Devices in Clinic
Figure 10. Global Opthalmology Drugs and Devices Market: Clinic (2016-2021) & ($ Millions)
Figure 11. Opthalmology Drugs and Devices in Others
Figure 12. Global Opthalmology Drugs and Devices Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Opthalmology Drugs and Devices Market Size Market Share by Application in 2020
Figure 14. Global Opthalmology Drugs and Devices Revenue Market Share by Player in 2020
Figure 15. Global Opthalmology Drugs and Devices Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Opthalmology Drugs and Devices Market Size 2016-2021 ($ Millions)
Figure 17. APAC Opthalmology Drugs and Devices Market Size 2016-2021 ($ Millions)
Figure 18. Europe Opthalmology Drugs and Devices Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Opthalmology Drugs and Devices Market Size 2016-2021 ($ Millions)
Figure 20. Americas Opthalmology Drugs and Devices Market Size Market Share by Country in 2020
Figure 21. Americas Opthalmology Drugs and Devices Market Size Market Share by Type in 2020
Figure 22. Americas Opthalmology Drugs and Devices Market Size Market Share by Application in 2020
Figure 23. United States Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Opthalmology Drugs and Devices Market Size Market Share by Regions in 2020
Figure 27. APAC Opthalmology Drugs and Devices Market Size Market Share by Type in 2020
Figure 28. APAC Opthalmology Drugs and Devices Market Size Market Share by Application in 2020
Figure 29. China Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Opthalmology Drugs and Devices Market Size Market Share by Country in 2020
Figure 36. Europe Opthalmology Drugs and Devices Market Size Market Share by Type in 2020
Figure 37. Europe Opthalmology Drugs and Devices Market Size Market Share by Application in 2020
Figure 38. Germany Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Opthalmology Drugs and Devices Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Opthalmology Drugs and Devices Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Opthalmology Drugs and Devices Market Size Market Share by Application in 2020
Figure 46. Egypt Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Opthalmology Drugs and Devices Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 52. APAC Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 53. Europe Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 55. United States Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 56. Canada Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 59. China Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 60. Japan Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 61. Korea Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 63. India Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 64. Australia Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 65. Germany Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 66. France Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 67. UK Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 68. Italy Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 69. Russia Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 70. Spain Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 73. Israel Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Opthalmology Drugs and Devices Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 안과 약물 및 기기 시장예측 2021년-2026년] (코드 : LPI-2201K02251) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 안과 약물 및 기기 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 소아용 의약품 및 백신 시장예측 2021년-2026년
LPI-2201K02138 / LP Information / 2021년 12월 / 본 조사보고서는 소아용 의약품 및 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Pediatric Drugs and Vaccines will have significant change from previous year. By the most conservative estimates of global Pediatric Drugs and Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 93410...

세계의 일로프로스트 약물 시장예측 2021년-2026년
LPI-2201K00058 / LP Information / 2021년 12월 / 본 조사보고서는 일로프로스트 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Iloprost Drugs will have significant change from previous year. By the most conservative estimates of global Iloprost Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 90 million in 2020. Over...

세계의 불임 치료제 시장예측 2021년-2026년
LPI-2201K00069 / LP Information / 2021년 12월 / 본 조사보고서는 불임 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Infertility Drugs will have significant change from previous year. By the most conservative estimates of global Infertility Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4687.8 million in 2020. Over...

세계의 췌장암 치료제 시장예측 2021년-2026년
LPI-2201K02132 / LP Information / 2021년 12월 / 본 조사보고서는 췌장암 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pancreatic Cancer Drugs will have significant change from previous year. By the most conservative estimates of global Pancreatic Cancer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 퀵 완화 천식 약물 시장예측 2021년-2026년
LPI-2201K02286 / LP Information / 2021년 12월 / 본 조사보고서는 퀵 완화 천식 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Quick-relief Asthma Drugs will have significant change from previous year. By the most conservative estimates of global Quick-relief Asthma Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 반려 동물용 항감염제 시장예측 2021년-2026년
LPI-2201K02141 / LP Information / 2021년 12월 / 본 조사보고서는 반려 동물용 항감염제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Pets Anti-infective Drugs will have significant change from previous year. By the most conservative estimates of global Pets Anti-infective Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 오시머티닙 약물 시장예측 2021년-2026년
LPI-2201K02124 / LP Information / 2021년 12월 / 본 조사보고서는 오시머티닙 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Osimertinib Drugs will have significant change from previous year. By the most conservative estimates of global Osimertinib Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...